These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 25504022

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS.
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [Abstract] [Full Text] [Related]

  • 3. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Kim HJ, Cho A, Yun M, Kim YT, Kang WJ.
    Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
    [Abstract] [Full Text] [Related]

  • 4. Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.
    Kitajima K, Suenaga Y, Ueno Y, Maeda T, Ebina Y, Yamada H, Okunaga T, Kubo K, Sofue K, Kanda T, Tamaki Y, Sugimura K.
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1268-75. PubMed ID: 25833351
    [Abstract] [Full Text] [Related]

  • 5. Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort.
    Ironi G, Mapelli P, Bergamini A, Fallanca F, Candotti G, Gnasso C, Taccagni GL, Sant'Angelo M, Scifo P, Bezzi C, Bettinardi V, Rancoita PMV, Mangili G, Bocciolone L, Candiani M, Gianolli L, De Cobelli F, Picchio M.
    Clin Nucl Med; 2022 Mar 01; 47(3):e221-e229. PubMed ID: 35067539
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
    Signorelli M, Guerra L, Buda A, Picchio M, Mangili G, Dell'Anna T, Sironi S, Messa C.
    Gynecol Oncol; 2009 Nov 01; 115(2):231-5. PubMed ID: 19695685
    [Abstract] [Full Text] [Related]

  • 10. Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer.
    Mapelli P, Ironi G, Bergamini A, Mangili G, Rancoita PM, Taccagni GL, Venturini E, Petrone M, Nisi V, Fallanca F, De Marzi P, Colarieti A, Candotti G, Bocciolone L, Candiani M, Gianolli L, Picchio M, De Cobelli F.
    Nucl Med Commun; 2020 Oct 01; 41(10):1073-1080. PubMed ID: 32925826
    [Abstract] [Full Text] [Related]

  • 11. Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.
    Lee HJ, Ahn BC, Hong CM, Song BI, Kim HW, Kang S, Jeong SY, Lee SW, Lee J.
    Nuklearmedizin; 2011 Oct 01; 50(5):204-13. PubMed ID: 21727990
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of 18F-FDG PET/MRI for staging in patients with endometrial cancer.
    Tsuyoshi H, Tsujikawa T, Yamada S, Okazawa H, Yoshida Y.
    Cancer Imaging; 2020 Oct 22; 20(1):75. PubMed ID: 33092631
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.